Related Experiment Videos
Mechanical unloading with a miniaturized axial flow pump (hemopump): an experimental study
F R Waldenberger1, P Wouters, E deRuyter
1Department of Cardiac Surgery, Katholieke Universiteit Leuven, Belgium.
Artificial Organs
|July 1, 1995
Summary
The 21-F Hemopump significantly speeds recovery from myocardial stunning by reducing cardiac workload. The 14-F Hemopump showed minimal hemodynamic effects and no impact on recovery.
Area of Science:
- Cardiovascular Physiology
- Medical Device Engineering
Background:
- Regional myocardial stunning is a critical condition affecting heart function.
- Miniaturized axial flow pumps, like the Hemopump, are designed for cardiological applications.
- Assessing the unloading properties of these devices is crucial for clinical efficacy.
Purpose of the Study:
- To evaluate the unloading efficacy of the 14-F and 21-F Hemopumps in a sheep model of regional myocardial stunning.
- To compare the effects of mechanical unloading during ischemia versus reperfusion.
- To determine if the 21-F Hemopump enhances recovery from myocardial stunning.
Main Methods:
- An experimental setup was created to model regional myocardial stunning in sheep.
- Myocardial stunning was induced by coronary artery occlusion followed by reperfusion.
- Regional myocardial function was assessed using sonomicrometry, comparing control groups with groups undergoing mechanical unloading with Hemopumps.
Main Results:
- The 21-F Hemopump significantly accelerated recovery from myocardial asynchrony compared to the control and 14-F Hemopump groups.
- Mechanical unloading with the 21-F Hemopump during ischemia or early reperfusion enhanced functional recovery.
- The 14-F Hemopump demonstrated only minor hemodynamic effects and no significant impact on recovery.
Conclusions:
- Mechanical unloading with the 21-F Hemopump is effective in enhancing recovery from regional myocardial stunning.
- The 14-F Hemopump has limited impact on hemodynamics and recovery in this model.
- The 21-F Hemopump shows promise for improving outcomes in conditions involving myocardial stunning.